Background: Epithelial barrier dysfunction is a central feature in the pathogenesis
| INTRODUCTION
Epithelial barrier dysfunction is believed to be a central feature in the pathogenesis of allergic disease. In asthma, the airway epithelium undergoes dramatic changes, characterized by deficient differentiation and repair, loss of junctional and innate defense proteins, modification of extracellular matrix, and subepithelial fibrosis, together indicating loss of competent barrier functionality even in mild forms of disease. Dysregulation of epithelial-mesenchymal signaling consistent with epithelial-to-mesenchymal transition (EMT) has been proposed as one of the mechanisms responsible for dysfunction of the epithelial barrier in allergy. [1] [2] [3] Although existence of EMT-like processes has recently been implicated in multiple allergic diseases, including asthma, 2-5 specific drivers of EMT and their relationship to disease severity is the subject of controversy.
Chronic inflammation in asthma is sufficient to inflict damage on the epithelial barrier and induce repair process, which in part engages EMT as a mechanism to either expand the mesenchymal precursor pool, or induce adjacent epithelial cells to adopt a more migratory phenotype needed to regenerate a functional mature epithelium. Given persistence of chronic inflammation, ongoing and deficient repair would explain the presence of EMT and loss of barrier function. However, it has been increasingly recognized that barrier disruption may extend beyond simple inflammatory insult and even pre-date development of allergic disease. This is supported by the link between loss of function in epithelial barrier genes and allergen sensitization, 6 the altered barrier state of intact nonlesional skin in atopic dermatitis, 7 and increased transepidermal water loss (TEWL) through uninvolved skin of allergic patients. 8 Intriguingly, primary epithelial cells cultured from asthmatic airways, taken out of their inflammatory context, similarly exhibit a persistent altered "immature" phenotype with altered junctions and defective repair mechanisms. 9, 10 Collectively, these reports indicate persistence of epithelial dysfunction even after epithelial cells have been removed from the in vivo inflammatory environment. This suggests a transcriptional reprogramming (nonheritable alteration of cell development) of the epithelial phenotype and existence of systemic factors driving EMT and de-differentiation beyond the injury and repair.
Reprogramming of epithelial cells toward pro-mesenchymal phenotype has been shown to occur at the level of epigenetics, microRNA regulation, and metabolism. [11] [12] [13] However, the genes, pathways, and other factors involved in promoting this aberrant developmental program in asthma are poorly understood.
Here, we used unbiased biological gene network analysis to revi- 
| MATERIALS AND METHODS

| Microarray studies, datasets, and clinical sample characteristics
Gene Expression Omnibus (GEO), NCBI's publically available repository of bioinformatics datasets, which holds curated MIAME (Minimum Information About a Microarray Experiment) compliant transcriptomics data, was thoroughly queried for all datasets involving asthmatic epithelium. Only datasets supported by peer-reviewed PubMed-indexed publications, with well-documented clinical descriptions of asthma patients and airway sampling procedures, with sufficient samples to generate a robust list of significantly different genes with FDR significance adjustment, and with proper inclusion of healthy control groups, were selected for this study. A description of all considered microarray datasets found involving asthmatic epithelium, and reasoning for inclusion or noninclusion in this study, can be found in Table S1 . Based on these criteria, eight gene expression microarray datasets representing different independent studies of asthma were downloaded from the repository. Datasets from different asthma severities were intentionally included, for the purpose of identifying unifying factors across different asthmatic subtypes.
Seven of eight datasets utilized in this study were derived from bronchial brushings of normal vs asthmatic patients, immediately lysed for RNA extraction upon sampling. To control for contaminating expression of genes from cell types other than epithelium, a dataset of epithelial samples cultured from epithelial brushings (where only adherent cells were passaged >3 times in plates before RNA extraction) was included as an internal control. Gene annotations were updated using technology-corresponding annotation libraries in R. The GEO and PubMed NCBI accession numbers, as well as details of each microarray study, including sample descriptions (brief patient demographics, asthma severity, and epithelial purity), are provided in Table 1 . Our workflow for bioinformatics analysis is illustrated in Figure 1 . Genes were deemed "functional hub" genes if they belonged to more than one functional metagroup, suggesting a more central role in regulation of biological processes in asthmatic epithelium. Networks generated utilizing this analysis were exported in GLM format for further analysis and visualization, using the "iGraph" package (R). functional metagrouping of genes. The "OmicCircos" package (R) was used to perform hierarchical clustering, and to visualize gradient of severity in normalized fold change of the 159 consensus genes across all studies of asthma, using circular heatmap display.
| Gene validation in independent epithelial brushings datasets
One approach we took for validation of our signatures involved interrogation of publically available independent microarray studies of normal vs asthmatic epithelium that were not initially included in our signature, GSE41861 and GSE64913. Reasons for not including these datasets in our initial analysis were lack of publication in peer-reviewed, PubMedindexed work (GSE41861) and mixed sampling from peripheral and central bronchi (GSE64913). These studies were technically sound (properly powered and allowed for FDR adjustment), and both datasets were processed identically to the datasets from our comparative analysis. Both new microarray datasets utilized freshly isolated bronchial brushings for their epithelial samples, similar to the source for most of the microarray datasets used in our mining analysis. GSE41861 represented mild, moderate, and severe asthma. GSE64913 included only severe asthmatics in its analysis. To identify genes confirming their expression in these independent cohorts, lists of significantly differentially expressed genes from these studies were blasted against our asthma convergence signatures using Venn analysis. were used for tests in different conditions. When comparing healthy and asthmatic samples, donors were matched by age and sex. All samples were processed simultaneously for downstream analyses.
| RNA-Seq sequencing and analysis of epithelial samples
Epithelial cells were immediately lysed using RLT buffer from the Qiagen RNeasy Plus Mini kit (Qiagen, Hilden, Germany). Cell lysates were stored at À80°C until RNA was extracted. RNA isolations were performed using Qiagen RNeasy Plus Mini kit (Qiagen). RNA quality and quantity were measured using Agilent 4200 Tapestation using "edgeR" package (R, Bioconductor) was used to analyze sequencing data. Briefly, reads were assessed for quality, aligned to hg19 human reference genome using TopHat algorithm, and normalized and annotated count data were analyzed for differential expression using "deseq2" protocol. All resulting RNA-seq data will be made publically available in NCBI's GEO Omnibus repository. 
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F I G U R E 2 Circular visualization of chromosomal positions, hierarchical clustering, connectivity, and severity gradients for all genes in the asthma 159 gene convergence signature. The eight different microarray datasets are represented by concentric circles radiating outwards from the middle of the circle, with the "mild" asthma studies in the innermost group, the "moderate" asthma studies in the middle group, and the "severe" asthma studies in the outermost group. The specific order of studies, from innermost to outermost, is the same as the order they are listed in Table 1 (TLE1, NTRK2, POSTN, FGFR1, INSR, IRS2, FGFR2,  EFNB2 , VEGFA, NR3C1, CTNNB1, and NOTCH2) plotted for each gene in each of the eight microarray datasets utilized in this study (12 genes98 studies=96 points in total). Points from studies of "mild" asthma are denoted in blue; "moderate," purple; "severe," red.
Medians of all Àlog 10 -adjusted P-values for all 12 genes in each severity grouping of array datasets (mild, moderate, severe) are shown with color-coded dotted lines to demonstrate an overall trend of increase in significance corresponding to increase in severity. Data points with the highest values on volcano plot are labeled with corresponding gene names. B, Line chart depicting the change in Àlog 10 -adjusted P-value as disease severity increases (based on FEV1), for each of the 12 hub genes. Gene data points in each severity group (mild, moderate, severe) are Àlog 10 -adjusted Pvalues averaged for all studies falling within given severity group F I G U R E 4 Validation of 12 epithelial differentiation genes in an independent study of mild, moderate, and severe asthma (GSE41861).
Normalized expression values in each sample in GSE41861 (across different asthma severities) for the 12 epithelial differentiation "functional hub" genes identified in our network analysis. ****: P-value <.0001; ***: P-value <.001; **: P-value <.01; *: P-value <.05; n. 
| Epithelial de-differentiation programs in mild, moderate, and severe asthma
Given that the consensus asthma signature of 159 genes is represented in mild, moderate, and severe asthma datasets, we determined whether expression of these genes changes with disease severity. FEV1 (forced expiratory volume) data representing asthma severity for each of the eight studies are shown in Table 1 . Hierarchical clustering of these genes by normalized fold change indicated that overall, expression of most genes in the consensus signature increases with severity, represented by its intensification along the FEV1 gradient (Figure 2 ). This was also true for our "12 gene epithelial differentiation signature" representing dysregulation of the epithelial differentiation program within this signature (Figure 2 ,
Functional network analysis of consensus asthma gene expression signature. Functional network of 159 genes that were significantly differentially expressed (10% FDR-adjusted P-value cutoff) in the same direction (93 upregulated and 66 downregulated) in at least five of eight asthma microarray datasets shown in Table 1 . The functional gene network was generated by metagrouping of individual gene term sets (referencing GO Biological Process and KEGG Pathways knowledge repositories), based on functional similarity. Each color-defined gene cluster represents a single metagroup defined by functional similarity of biological processes involving these genes, labeled accordingly in matching color adjacent to gene clusters. Genes unique to their corresponding metagroups are color-coded. Nodes representing "functional hub" genes (belonging to multiple metagroups) are not color-coded. 12 genes belonging to functional processes representing epithelial morphogenesis and differentiation (as indicated by an unbiased gene term analysis) are displayed in larger fonts and node sizes than other genes. Genes in red were significantly upregulated, while genes in blue were significantly downregulated. Edge (line) thickness is proportional to weight of gene interaction in the network. Connections between hub genes with the highest weight and overall connectivity in the network colored gene labels). Moreover, there was an overall trend for increase in statistical significance of these genes, aligning with sever- were most significantly differentially expressed in moderate asthma, while EFNB2 and NTRK2 showed similar levels of statistical significance in moderate and severe asthma ( Figure 3B ). In summary, this epithelial de-differentiation program appears to occur to some degree in mild, moderate, and severe asthma. Moreover, expression of key genes representing this process tends to increase with disease severity.
| Convergent gene validation in independent epithelial brushing datasets
To validate our convergence gene signatures and functional processes revealed through the data mining analysis, we utilized two different approaches. First, we determined whether these genes appear in other independent publicly available microarray datasets of asthma (GSE41861 and GSE64913) that were not included in the original eight datasets used in our analysis. The reasoning for not including them in our initial analysis is described in the Methods and Table S1 . Importantly, these datasets were also performed on freshly lysed bronchial brushing samples, similar to the majority of datasets used to generate our convergence signatures. We specifically assessed the significance of differential expression of our 12 functional hub genes most relevant to epithelial-mesenchymal communication in each of these microarray datasets (Figure 4 and 
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F I G U R E 6 Key genes capturing epithelial de-differentiation program in asthma. A, Radar plot comparing significant expression of classical epithelial-to-mesenchymal transition (EMT) markers in the eight microarray datasets with the expression of key genes identified from functional gene network analysis in Figure 5 , in the same microarray datasets. Each sector of the circle represents a different gene, and gene symbols are listed on the outside of the corresponding sector. Green: conventional EMT markers. Red: upregulated key genes from our signature (associated with induction of EMT program). Blue: downregulated hub genes from our signature (representing de-differentiation). Concentric lines within the circle radiating outwards from the center denote the number of studies in which a gene occupying any given sector was identified as significantly differentially expressed (ie, genes highlighted in three concentric circles are differentially expressed in three of eight asthma studies). B, PubMed results returned for queries involving key genes included in the plot above, coupled with other search terms including asthma, EMT, and epithelial differentiation. Details of each query are shown in the legend; each query first includes the gene name and associated protein name, followed by "asthma," "EMT," or "epithelial differentiation" (made as inclusive as possible using AND and OR search operators). The number of studies returned by these PubMed searches is denoted numerically over separate bar graphs for each gene [Colour figure can be viewed at wileyonlinelibrary.com] moderate, and severe asthma (all simultaneously performed in the same study), and this study also confirmed potentiation of differences in expression of genes of interest along the asthma severity gradient (Figure 4 ). Notably, fold change and significance of these changes tended to increase in more biologically relevant organotypic contexts (note changes in scale in different conditions in Figure 7 ), which we additionally emphasized in Figure 8 . 
| DISCUSSION
Our study was motivated by the controversy surrounding epithelialto-mesenchymal transition in asthma. Existence of EMT, potential drivers of this process, and its causal versus consequential place in the pathogenesis of allergic disease are some of the most contested issues in the field. 15, 16 Access to a shared library of transcriptomic data from the scientific community in web repositories such as Gene Expression Omnibus (GEO, NCBI) provides a unique opportunity to revisit gene expression signatures from multiple independent studies in search of agreement on processes underlying disease pathogenesis. 17 Understanding convergence among independent studies of one disease, when conducted in an unbiased manner, represents a pow- These include markers attributable to mature epithelium, mesenchymal/basal epithelium, "Th2-high" barrier markers, and genes associated with active epithelial differentiation. Bar graphs represent log 2 (fold change) of asthmatic or insulin-deficient normal epithelium vs normal controls, based on normalized RNA transcript counts. The same donors were used in all three scenarios, and asthmatic vs normal donors were matched by age and sex. ****: P-value <.0001; ***: P-value <.001; **: P-value <.01; *: P-value <.05; n. Figure 7 . B, Venn diagrams comparing 159 asthma convergence signature (left) and 12 gene epithelial differentiation signature (right) against gene expression in epithelial brushings (from GSE41861), stratified by mild, moderate, and severe asthma, as presented in Figure 4 . C, Summary charts contrasting the strength of convergence signature validation in different biological sources and culture contexts. The number of genes denoted over individual bars in bar graphs matches the number of genes in corresponding intersections in the Venn diagrams above epithelial barriers. 3 Moreover, many transcriptional drivers of EMT are proteins with short half-lives, 18 so that their stabilization by local cues can cause rapid changes in gene expression. 19 Thus, one might not expect to observe consistent differences in the mRNA levels of these factors. Additionally, unlike cancer, where epithelial cells are considered to undergo a full transition to a mesenchymal phenotype in order to migrate to and colonize other sites in the body, 20 EMT in allergy is more often reported as a mild, "partial" phenotype. 6 the altered barrier state of intact nonlesional skin in atopic dermatitis, 7 increased transepidermal water loss (TEWL) through uninvolved skin of allergic patients, 8 and "immaturity" defects in junctional maintenance and repair in cultured asthmatic epithelium. 10 However, no mechanism has been proposed so FGF21, a novel hormone partnering with insulin in regulation of glucose homeostasis, also signals through FGFR1 and FGFR2. 39 In support of our findings, previous studies have reported insulin resistance in children and adults with asthma, 40, 41 and an association of asthma with prediabetes and metabolic syndrome. 49, 50 suggesting an intriguing possibility that these processes play a role in the origins and predisposition to allergic disease.
A persistent phenotype of repair deficiencies in epithelial cultures from asthmatic children further implicates developmental tissue reprogramming and supports this possibility. 10 Metabolic and endocrine components of asthma pathogenesis are not well understood and are the subject of current and future studies by our group.
Asthma is a highly heterogeneous disease represented by several clinical and molecular endotypes. 51 For example, previous gene expression studies have demonstrated existence of Th2-low and Th2-high subtypes of asthma. 32 In particular, severe asthma resistant to glucocorticoid treatment is thought to involve distinct pathogenic mechanisms and represent a separate endotype of this highly complex disease. 52 Despite numerous differences in immune and regulatory responses in different forms of asthma, the consensus gene expression program revealed by our analysis implicates the underlying "core" de-differentiation program as a potentially unifying feature of asthma that spans several different endotypes, given its persistence throughout mild, moderate, and severe asthma, as well as in studies performed by several independent groups. Importantly, expression of most genes within our 159 gene asthma consensus signature increases with disease severity, implying that common overarching mechanisms may be shared by all forms of disease, only on different spectrums. Interestingly, our study found that downregulation of the glucocorticoid receptor (GR) (NR3C1 gene) was the most dramatic in severe asthma, while showing comparatively modest downregulation in mild and moderate asthma. Thus, an intriguing possibility is that insufficient levels of GR (relative to mild and moderate asthma) contribute to glucocorticoid treatment resistance in severe asthma. It is also important to recognize that besides its role in the control of inflammation, GR is part of a mechanism regulating tissue and epithelial barrier homeostasis. Inactivation of GR triggers barrier defects, epithelial de-differentiation, and inflammation, [53] [54] [55] [56] which is rationalized by our gene network analysis showing the interconnectivity of NR3C1 dysregulation with processes governing epithelial differentiation ( Figure 5 ), where dramatic downregulation of NR3C1 in severe asthma coincides with upregulation of FGFR1 and TLE1-inducers of an "immature" state of the epithelium (Figure 3) .
In summary, our study neither refutes nor supports the existence of EMT in asthma as classically defined by developmental biologists, 
